JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vaccari, A.
Right arrow Articles by Tanganelli, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vaccari, A.
Right arrow Articles by Tanganelli, S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DISULFIRAM
*GLUTAMIC ACID HYDROCHLORIDE
*METHYLAMINE
*SODIUM DIETHYLDITHIOCARBAMATE

Vol. 285, Issue 3, 961-967, June 1998

Differential Mechanisms in the Effects of Disulfiram and Diethyldithiocarbamate Intoxication on Striatal Release and Vesicular Transport of Glutamate1

Andrea Vaccari, Luca Ferraro, Pierluigi Saba, Stefania Ruiu, Ignazia Mocci, Tiziana Antonelli and Sergio Tanganelli

"Bernard B. Brodie" Department of Neuroscience, Neurotoxicology Unit, University of Cagliari (A.V., P.S., S.R., I.M., S.T.), Cagliari, Italy and Department of Clinical and Experimental Medicine, Pharmacology Section (L.F., T.A.), Ferrara, Italy

Intoxication with the alcohol-aversive drug disulfiram (Antabuse) and related dithiocarbamates may provoke neuropathies and, in some cases, damage the basal ganglia. Rats received a single administration of disulfiram (7 and 500 mg kg-1 i.p.) and equimolar doses (4 and 290 mg kg-1 i.p.) of its metabolite diethyldithiocarbamate (DDC), roughly corresponding to the daily maximum dose in alcohol abusers or to an estimated nonlethal overdose, respectively. The striatal, extracellular levels of glutamate in freely moving rats previously implanted with a microdialysis probe increased after low and intoxicating doses of disulfiram (126 ± 3% and 154 ± 10% of basal values, respectively) and DDC as well (135 ± 10% and 215 ± 14%, respectively), a partially Ca++-dependent effect. The prolonged (>7 hr) disulfiram-induced increase in glutamate observed in vivo may reflect the in vitro disulfiram-evoked release of glutamate from striato-cortical synaptic vesicles, where the drug nonspecifically inhibited (Ki approx 4 µM) the uptake function and abolished the transmembrane proton gradient (Delta pH). In contrast, DDC did not seem to affect Delta pH. The prompt DDC-provoked increase in extracellular levels of glutamate was prevented by 7-nitroindazole, an in vivo specific inhibitor of neuronal nitric oxide synthase, which suggests that the thiol metabolite also acts via the nitric oxide synthesis. At variance, the short-acting 7-nitroindazole did not prevent the sustained in vivo effects of disulfiram and of DDC putatively formed with time. These findings provide new evidence for differential mechanisms underlying disulfiram- and DDC-induced increases in striatal glutamate release. Present glutamatergic changes, although not appearing dramatic enough to represent the only cause for neuronal damage from disulfiram overdose, might contribute to the drug neurotoxicity.


0022-3565/98/2853-0961$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Toxicol SciHome page
R. M. LoPachin and D. S. Barber
Synaptic Cysteine Sulfhydryl Groups as Targets of Electrophilic Neurotoxicants
Toxicol. Sci., December 1, 2006; 94(2): 240 - 255.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Thiruchelvam, E. K. Richfield, R. B. Baggs, A. W. Tank, and D. A. Cory-Slechta
The Nigrostriatal Dopaminergic System as a Preferential Target of Repeated Exposures to Combined Paraquat and Maneb: Implications for Parkinson's Disease
J. Neurosci., December 15, 2000; 20(24): 9207 - 9214.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Vaccari, P. Saba, I. Mocci, and S. Ruiu
Dithiocarbamate Pesticides Affect Glutamate Transport in Brain Synaptic Vesicles
J. Pharmacol. Exp. Ther., January 1, 1999; 288(1): 1 - 5.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.